Skip to main content
Log in

Optimization Studies on Prokaryotic Cell Expression of the Human Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The aim of the study was to optimize the in vitro induction and expression of the human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and also study the processes of its denaturation, renaturation, and purification. The pGEX-6P-1/TRAIL114–281 plasmid was induced by isopropyl-β-d-1-thiogalactopyranoside (IPTG) in Escherichia coli BL21 (DE3), and the expressed target protein was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The protein expressed in the form of inclusion body was first denaturalized and then renaturalized by dilution and dialysis technique. GST-rTRAIL114–281 fusion protein was purified by Glutathione-Superflow Resin affinity chromatography and confirmed by Western blot. The molecular weight of GST-rTRAIL expressed in E. coli BL21 (DE3) was approximately 40 kDa. GST-rTRAIL was mainly expressed in the form of inclusion bodies. An optimum expression was induced by IPTG at a concentration of 0.2 mM for 8 h at 37 °C. Glutathione-Superflow Resin affinity chromatography yielded the purified GST-rTRAIL protein which was confirmed by Western blot using anti-GST mouse monoclonal antibody. The optimum prokaryotic cell expression of the human GST-rTRAIL was obtained by 0.2 mM IPTG induction for 8 h at 37 °C. The denatured inclusion body protein can be refolded by dilution and dialysis and purified by Glutathione-Superflow Resin affinity chromatography.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Hao, L., Shi, Z. D., & Han, C. H. (2009). Anti-tumor effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). Progress in Modern Biomedical, 20, 3983–3985.

    Google Scholar 

  2. Zoog, S. J., Ma, C. Y., Kaplan-Lefko, P. J., Hawkins, J. M., Moriguchi, J., Zhou, L., et al. (2010). Measurement of conatumumab-induced apoptotic activity in tumors by fine needle aspirate sampling. Cytometry Part A, 77, 849–860.

    Article  Google Scholar 

  3. Sanlioglu, A. D., Karacay, B., Koksal, I. T., Griffith, T. S., & Sanlioglu, S. (2007). DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5 hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells. Cancer Gene Therapy, 14, 976–984.

    Article  CAS  PubMed  Google Scholar 

  4. Chen, J. Q., Zhu, C. S., Gong, Z. Y., & Zhao, J. H. (2007). Cloning of soluble hTRAIL tumor-specific vector and expression in nasopharyngeal carcinoma cell line CNE-2. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 13, 407–410.

    CAS  Google Scholar 

  5. Wang, D., & Shi, L. (2009). High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Applied Biochemistry and Biotechnology, 157, 1–9.

    Article  CAS  PubMed  Google Scholar 

  6. Song, J. H., Tse, M. C., Bellail, A., Phuphanich, S., Khuri, F., Kneteman, N. M., et al. (2007). Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Research, 67, 6946–6955.

    Article  CAS  PubMed  Google Scholar 

  7. Wang, J., Yu, W. H., Kang, S. L., & Xiao, K. F. (2005). Antitumor activity of recombinant soluble human TRAIL. Journal of Wuhan University (Natural Science Edition), 51, 467–471.

    CAS  Google Scholar 

  8. Liu, Z. Z., Hao, L., Fan, T., He, H. G., You, H. J., Tang, R. X., & Han, C. H. (2011). Construction and identification of prokaryotic expression vector of human TNF-related apoptosis inducing ligand. Progress in Modern Biomedical, 11, 1220–1223.

    Google Scholar 

  9. Tian, S. H., & Quan, J. W. (2005). Expression of extracellular domain gene of human TRAIL in E. coli and re-naturalization of inclusion body. Chinese Journal of Biologicals, 18, 114–116.

    CAS  Google Scholar 

  10. Liu, C. Y., Gao, D., & Xu, F. H. (2010). Prokaryotic expression and in vitro antitumor activity of TNF-related apoptosis inducing ligand114-281-IL24 fusion protein. Chinese Journal of Biologicals, 23, 913–917.

    CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr. Ming Zhang, The Liver Transplant Center, Ren Ji Hospital, Shanghai Jiaotong University, for his kind advice. This work was supported by National Natural Science Foundation of China [Grant Number 81272557].

Conflict of interest

The authors declare that there are no conflict of interest involved.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cong-Hui Han.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hao, L., Zhang, ZG., Shi, ZD. et al. Optimization Studies on Prokaryotic Cell Expression of the Human Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Cell Biochem Biophys 73, 275–279 (2015). https://doi.org/10.1007/s12013-015-0596-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-015-0596-6

Keywords

Navigation